Close Search
JDDonline - Journal of Drugs in Dermatology
  • Home
  • Issues
    • Current Issue
    • eJDD
    • Featured Articles
    • Archived Issues
    • Supplement Library
    • Case Reports
    • Unlocked Access
    • JDD Corner
    • Clinical Solutions
  • Topics
    • Atopic Dermatitis
    • Oats in Skincare
    • Oncoderm
    • Pigmentary Disorders
    • Psoriasis
    • Inclusive Dermatology Atlas
    • Social and Technology
    • Latest News
  • CME
    • CME Activities
  • Multimedia
    • JDD Corner
    • Video Abstracts
    • Podcast
    • Webinars
    • Translational Lecture Series
    • Video Pearls
  • Info
    • About JDD
    • Advertisers
      • Media Kit
      • Podcast Sponsorship
      • Reprints Contact Us
    • Authors
      • Instructions to Authors
      • Submit a Manuscript
      • Author and Peer Review Login
    • Editorial Board
    • Events
    • Contact Editorial
    • Why Publish in the JDD?
    • Institutional, Library, & Corporate Subscriptions
    • Reprints Contact Us
    • SanovaWorks
  • Inclusive Derm Atlas
    • Online Gallery
    • Digital Edition
  • Subscribe Now
  • Log In
  • x-twitter facebook linkedin instagram
Jan 31
Love0

Practical Algorithm for Acne Treatment Integrating Skincare and Energy-Based Devices

By Chuck Lin No Comments
INTRODUCTIONDespite the growing use of energy-based devices (EBDs) in dermatology, there remains a lack of structured guidance for clinicians on combining EBDs with skin care in acne and post-acne sequelae…
Read More
Jan 31
Love0

ChatGPT and DeepSeek in Dermatologic Practice: Do Artificial Intelligence Models Adhere to Psoriasis Treatment Guidelines?

By Chuck Lin No Comments
INTRODUCTIONMachine learning (ML), a subset of artificial intelligence (AI), is a computational approach that utilizes input data to achieve specific goals without relying on explicitly programmed instructions.1 Large language models…
Read More
Jan 31
Love0

INDIVIDUAL ARTICLE: Evidence-Based Synthesis of Deucravacitinib: Long Term Efficacy, Safety, and Practical Use in Moderate-to-Severe Psoriasis

By Chuck Lin No Comments
INTRODUCTIONPsoriasis is a chronic, immune-mediated inflammatory skin disease affecting more than 125 million individuals worldwide.1-3 At the cellular level, aberrant activation of inflammatory pathways triggers keratinocyte hyperproliferation, resulting in the…
Read More
Jan 30
Love0

What Drives the Aesthetic Journey? A Survey of the Cosmetic Concerns for African-American Women

By Chuck Lin No Comments
INTRODUCTIONThe number of aesthetic procedures performed among African-American (AA) patients in the United States increased 43% between 2012 and 2019.1,2 Although there has been a recent focus on understanding the…
Read More
Jan 29
Love0

Enhancing Patient Privacy in Dermatology: Best Practices for Image Organization and Security

By Chuck Lin No Comments
To the Editor:The increasing use of digital images in dermatology for diagnostic and treatment purposes presents serious privacy and security concerns. Dermatologists routinely collect and retain photos of skin disorders,…
Read More
Jan 29
Love0

Excimer Laser for Plaque Psoriasis: A Systematic Review and Meta-analysis

By Chuck Lin No Comments
INTRODUCTIONPlaque psoriasis is a chronic inflammatory condition characterized by keratinocyte hyperproliferation and immune dysregulation that significantly impacts quality of life.1 While conventional therapies, such as topical corticosteroids and biologics, are…
Read More
Jan 29
Love0

GLP-1 Receptor Agonists in Overweight and Obese Patients With Hidradenitis Suppurativa

By Chuck Lin No Comments
INTRODUCTIONHidradenitis suppurativa (HS) is a chronic, multifactorial inflammatory disease that is influenced by obesity and metabolic dysfunction. Overweight and obese individuals may experience more severe HS due to increased skin…
Read More
Jan 29
Love0

Reducing Administrative Burden in Dermatology Through Compounding Alternatives

By Chuck Lin No Comments
Letter to the Editor: Administrative burdens, particularly prior authorization (PA) requirements and appeals, remain a significant barrier to timely dermatologic care. On average, physicians complete 39 PAs per week, dedicating…
Read More
Jan 29
Love0

Real-World Effectiveness of Lebrikizumab for the Prurigo Nodularis–Like Phenotype of Atopic Dermatitis: A One-Year Retrospective Study

By Chuck Lin No Comments
To the Editor: Atopic dermatitis (AD) presents with several phenotypes, among which the prurigo nodularis (PN)-like phenotype is particularly resistant to treatment.1 PN-like phenotype of AD is characterized by multiple…
Read More
Jan 29
Love0

The Senile Cell: Understanding Cellular Senescence in Dermatology

By Chuck Lin No Comments
INTRODUCTIONCellular senescence is a permanent and stable arrest of the cell cycle triggered by endogenous and exogenous stressors, such as DNA damage, oxidative stress, and telomere dysfunction.1,2 In this state,…
Read More
Jan 29
Love0

Reddit Discourse on Eczema: Quantitative Analysis of Misinformation, Engagement, and Alignment With 2025 American Academy of Dermatology Guidelines

By Chuck Lin No Comments
INTRODUCTIONAopic dermatitis (AD) is a chronic inflammatory disease with significant psychosocial burden.¹ Patients increasingly seek dermatological information and guidance on Reddit, a platform with over 70 million daily active users,…
Read More
Jan 29
Love0

Treatment of Generalized Granuloma Annulare With Biologics and Oral JAK Inhibitors: A Case Series

By Chuck Lin No Comments
INTRODUCTIONGranuloma annulare (GA) is a granulomatous inflammatory skin condition of unknown etiology, often presenting as annular plaques or papules.1 Generalized GA (GGA) is a rare subtype of GA characterized by…
Read More
« Previous
NextPrevious »

Search page

Advertisement

Popular

  • Hair Loss Awareness Month August 7, 2026
  • “Please sir, I want some more:” When Rescue Becomes Routine With Prednisone in IBD Care August 7, 2026
  • “Please sir, I want some more:” When Rescue Becomes Routine With Prednisone in IBD Care August 7, 2026
  • Photoprotection 2026: Clinical Updates, Global Trends, and the US Regulatory Evolution August 6, 2026
  • GLP-1 Receptor Agonist Use for Diabetes Mellitus is Associated With Reduced Psoriasis Disease Severity August 6, 2026

Advertisement

News Topics

  • Inclusive Derm Atlas
  • Atopic Dermatitis
  • CME
  • Featured Articles
  • Issue Highlights
  • Oats in Skincare
  • Oncoderm
  • Pigmentary Disorders
  • Psoriasis
  • Skin of Color
CONTACT US     |      FEEDBACK    |      TERMS     |      COOKIE POLICY    |     PRIVACY    |      EDITORIAL POLICY    |     ADVERTISING POLICY  |    MANAGE PREFERENCES  |  YOUR PRIVACY CHOICES

News Topics

  • Inclusive Derm Atlas
  • Atopic Dermatitis
  • CME
  • Featured Articles
  • Issue Highlights
  • Oats in Skincare
  • Oncoderm
  • Pigmentary Disorders
  • Psoriasis
  • Skin of Color
DermAtlas        Derm In-Review         PDE        Next Steps in Derm         Skin of Color Update     ODAC Dermatology, Aesthetic & Surgical Conference LVD        PDE       

Journal of Drugs in Dermatology

  • About Us
  • Contact Us
  • Contact Sales
  • Editorial Board
  • eJDD
  • Institutional, Library, & Corporate Subscriptions
  • Log In
  • Open Access
  • Permissions Request
  • Podcast Sponsorship
  • Subscription Info
  • Store

© 2026 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.

  • twitter
  • facebook
  • linkedin
  • instagram
Close Menu
  • Home
  • Issues
    • Current Issue
    • eJDD
    • Featured Articles
    • Archived Issues
    • Supplement Library
    • Case Reports
    • Unlocked Access
    • JDD Corner
    • Clinical Solutions
  • Topics
    • Atopic Dermatitis
    • Oats in Skincare
    • Oncoderm
    • Pigmentary Disorders
    • Psoriasis
    • Inclusive Dermatology Atlas
    • Social and Technology
    • Latest News
  • CME
    • CME Activities
  • Multimedia
    • JDD Corner
    • Video Abstracts
    • Podcast
    • Webinars
    • Translational Lecture Series
    • Video Pearls
  • Info
    • About JDD
    • Advertisers
      • Media Kit
      • Podcast Sponsorship
      • Reprints Contact Us
    • Authors
      • Instructions to Authors
      • Submit a Manuscript
      • Author and Peer Review Login
    • Editorial Board
    • Events
    • Contact Editorial
    • Why Publish in the JDD?
    • Institutional, Library, & Corporate Subscriptions
    • Reprints Contact Us
    • SanovaWorks
  • Inclusive Derm Atlas
    • Online Gallery
    • Digital Edition
  • Subscribe Now
  • Log In

Search

  • x-twitter
  • facebook
  • linkedin
  • instagram